Metraipolis › archive › dc_50ff2afb81ec

Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study — Europe PMC PMID:42539933

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42539933
DOI
10.7759/cureus.111855
License (as archived)
solo-consultazione
Archived
2026-10-18T14:20:57.865Z
SHA-256 of the archived text
c545c33d9ea25f4b8ac0588c39bfe45d5b5cd884a7abdbadbaba1b3a7ef64805
Stable URL of this page
https://metraipolis.com/documento/dc_50ff2afb81ec

How to cite

Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study — Europe PMC PMID:42539933 — Europe PMC (en), https://europepmc.org/article/MED/42539933 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50ff2afb81ec (Metraipolis archive dc_50ff2afb81ec, sha256 c545c33d9ea25f4b8ac0588c39bfe45d5b5cd884a7abdbadbaba1b3a7ef64805)
BibTeX
@misc{dc50ff2afb81ec,
  title = {Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study — Europe PMC PMID:42539933},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42539933},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50ff2afb81ec; sha256 c545c33d9ea25f4b8ac0588c39bfe45d5b5cd884a7abdbadbaba1b3a7ef64805},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42539933. Agents can read the archived copy with the MCP tool read_document.